Advertisement
Advertisement
U.S. Markets close in 2 hrs 39 mins
Advertisement
Advertisement
Advertisement
Advertisement

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.3300-0.3100 (-8.52%)
As of 04:00PM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/25/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.7400
52 Week Low 33.0900
50-Day Moving Average 34.4926
200-Day Moving Average 34.9427

Share Statistics

Avg Vol (3 month) 344.58k
Avg Vol (10 day) 362.32k
Shares Outstanding 510.22M
Implied Shares Outstanding 6N/A
Float 87.82M
% Held by Insiders 123.24%
% Held by Institutions 10.72%
Shares Short (Dec 14, 2021) 4173.81k
Short Ratio (Dec 14, 2021) 44.47
Short % of Float (Dec 14, 2021) 42.20%
Short % of Shares Outstanding (Dec 14, 2021) 41.70%
Shares Short (prior month Nov 14, 2021) 4137.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-11.21M
Diluted EPS (ttm)-1.4790
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.46M
Total Cash Per Share (mrq)1.41
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)21.04
Book Value Per Share (mrq)1.41

Cash Flow Statement

Operating Cash Flow (ttm)-4.47M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement